Figure 2.

Forest plot of the overall and subgroup pooled reported prevalence of Alzheimer's disease. Results are presented by sex, survey period, World Health Organization region, Human Development Index level, sample size, study design, diagnostic criteria, and data source. Markers represent pooled prevalence estimates, and horizontal lines indicate 95% confidence intervals. I2 and Q-test p-values describe within-subgroup heterogeneity, whereas p-values for subgroup analysis indicate differences between subgroups. Estimates were calculated using a random-effects model with the Freeman–Tukey double-arcsine transformation and were back-transformed to prevalence per 100 population.